CHAMPIONS ONCOLOGY, INC. Gain (Loss) on Termination of Lease
CHAMPIONS ONCOLOGY, INC. (CSBR) reported Gain (Loss) on Termination of Lease of $9.00 thousand for the 12-month period ending 2026-04-30, per its 10-K filed 2026-07-27.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnTerminationOfLease · last filed 2026-07-27
- CHAMPIONS ONCOLOGY, INC. gain (loss) on termination of lease for the quarter ending 2021-07-31 was $0.00, a 100.00% decline year-over-year.
- CHAMPIONS ONCOLOGY, INC. gain (loss) on termination of lease for the quarter ending 2020-07-31 was $75.00K.
- CHAMPIONS ONCOLOGY, INC. gain (loss) on termination of lease for the quarter ending 2019-07-31 was $0.00.
- CHAMPIONS ONCOLOGY, INC. gain (loss) on termination of lease for fiscal 2026 was $9.00K.
- CHAMPIONS ONCOLOGY, INC. gain (loss) on termination of lease for fiscal 2025 was $0.00.
- CHAMPIONS ONCOLOGY, INC. gain (loss) on termination of lease for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- CHAMPIONS ONCOLOGY, INC. gain (loss) on termination of lease for fiscal 2021 was $75.00K.
| Period end | Gain (Loss) on Termination of Lease 3 month | Gain (Loss) on Termination of Lease 6 month | Gain (Loss) on Termination of Lease 9 month | Gain (Loss) on Termination of Lease 12 month |
|---|---|---|---|---|
| 2026-04-30 | $9.00K 10-K · filed 2026-07-27 | |||
| 2026-01-31 | $9.00K 10-Q · filed 2026-03-12 | |||
| 2025-10-31 | $9.00K 10-Q · filed 2025-12-15 | |||
| 2025-04-30 | $0.00 10-K · filed 2026-07-27 | |||
| 2025-01-31 | $0.00 10-Q · filed 2026-03-12 | |||
| 2024-10-31 | $0.00 10-Q · filed 2025-12-15 | |||
| 2022-04-30 | $0.00 10-K · filed 2022-07-22 | |||
| 2022-01-31 | $0.00 10-Q · filed 2022-03-15 | |||
| 2021-10-31 | $0.00 10-Q · filed 2021-12-13 | |||
| 2021-07-31 | $0.00 10-Q · filed 2021-09-13 | |||
| 2021-04-30 | $75.00K 10-K · filed 2022-07-22 | |||
| 2021-01-31 | $75.00K 10-Q · filed 2022-03-15 | |||
| 2020-10-31 | $75.00K 10-Q · filed 2021-12-13 | |||
| 2020-07-31 | $75.00K 10-Q · filed 2021-09-13 | |||
| 2020-04-30 | $0.00 10-K · filed 2021-07-26 | |||
| 2020-01-31 | $0.00 10-Q · filed 2021-03-15 | |||
| 2019-10-31 | $0.00 10-Q · filed 2020-12-14 | |||
| 2019-07-31 | $0.00 10-Q · filed 2020-09-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |